Genzyme sues Dr Reddy's over Mozobil generic; Germany agrees to boost price on MS drug Sativex;

@FiercePharma: Big Pharma pressures U.K. officials on cancer drug use as special fund set to expire. More from PMLiVE | Follow @FiercePharma

@EricPFierce: market is growing rapidly but so is the number of drugs approved to treat it. Novartis gets in. Story | Follow @EricPFierce

> Sanofi's ($SNY) Genzyme unit sued Indian generics maker Dr. Reddy's Laboratories to defend its patents on the cancer drug Mozobil. Report

> GW Pharmaceuticals said German pricing authorities agreed to a new, higher price for Sativex, a treatment for multiple sclerosis symptoms. Report

> Perrigo recruited a former FDA official to head up its regulatory review activities. Report

> Supernus Pharmaceuticals ($SUPN) designated Catalent Pharma Solutions as its supplier for delayed-release technology employed in a recently launched epilepsy treatment. Report | More from FierceCRO

> The United Nations said there has been dramatic progress in the worldwide fight against AIDS, thanks to the growing availability of treatment. Report

Medical Device News

@FierceMedDev: Veracyte, a molecular diagnostic company, has filed plans for an IPO. Story | Follow @FierceMedDev

@DamianFierce: FDA device chief Jeffrey Shuren blogs about "landmark" UDI rule. More | Follow @DamianFierce

@MarkHFierce: RainDance, a maker of gene-sequencing tools, raised up to $35M in debt financing to keep the sales push going. Article | Follow @MarkHFierce

@MichaelGFierce: ICYMI: Bind collects $70.5M IPO to support Accurin tech. More from FierceDrugDelivery | Follow @MichaelGFierce

> SafeShot pulls in $9M to develop better pre-filled syringes. More

> AdvaMed: Medical device prices have plunged. News

> Report: Med tech industry on growth track despite obstacles. Item

Biotech News

@FierceBiotech: ICYMI Friday: San Diego biotech insider accused of shooting RNAi expert and brother-in-law. Article | Follow @FierceBiotech

@JohnCFierce: Perlmutter has been working hard to create a new narrative for R&D. More efficient, smarter, focused on winners. Legacy bites again. | Follow @JohnCFierce

@EmilyMFierce: NIH launches $45M Alzheimer's research effort, awards funds to 3 preclinical studies. Story from FierceBiotech Research | Follow @EmilyMFierce

> Biotech public records spur 'arms race' for investors. Article

> Merck R&D hammered by another setback as FDA rejects anesthesia drug (again). Story

> Roche lung cancer drug bags another 'breakthrough' at the FDA. News

> Ablynx lands $840M AbbVie deal on next-gen Humira successor. Article

CRO News

> Quintiles seals deal for Novella. News

> PPD lures UCB exec to head immunology. Report

> Capsugel expands in U.S., Europe. Item

> CMO Aesica puts up $48M to make diabetes drugs. Article

> Catalent lands manufacturing deal with Supernus. More

> InVentiv partners up for policy, site selection. Story

Biotech IT News

> BRAIN Initiative prioritizes better data storage and analysis. More

> Biotech broker fined $5,000 for venting on Facebook. Item

> FDA posts final guidance on electronic source data. Story

> Google hires ex-Genentech CEO to lead ambitious bio spinoff. Report

> Bioinformatics-driven Eisai subsidiary inks discovery alliance. News

> New York Genome Center opens $54M biomedical-research hub. Article

And Finally... Homeless patients have sued Nevada, saying the state mental hospital shipped them out of state to avoid paying for their care. Report (sub. req.)

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.